Ownership history in STEMPOINT CAPITAL LP · 4 quarters on record
This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in XENON PHARMACEUTICALS INC (XENE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 348,605 | +156,310 | +81.3% | 2.68% | $15.6M | $44.82 |
| 2025 Q3 | REDUCED | 192,295 | -82,338 | -30.0% | 1.55% | $7.7M | $40.15 |
| 2025 Q1 | REDUCED | 274,633 | -101,212 | -26.9% | 2.94% | $9.2M | $33.55 |
| 2024 Q4 | INITIATED | 375,845 | — | — | 3.68% | $14.7M | $39.20 |
As of 2025 Q4 — sorted by position size